835 related articles for article (PubMed ID: 31473236)
1. Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement.
Jilaihawi H; Zhao Z; Du R; Staniloae C; Saric M; Neuburger PJ; Querijero M; Vainrib A; Hisamoto K; Ibrahim H; Collins T; Clark E; Pushkar I; Bamira D; Benenstein R; Tariq A; Williams M
JACC Cardiovasc Interv; 2019 Sep; 12(18):1796-1807. PubMed ID: 31473236
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3.
Mauri V; Reimann A; Stern D; Scherner M; Kuhn E; Rudolph V; Rosenkranz S; Eghbalzadeh K; Friedrichs K; Wahlers T; Baldus S; Madershahian N; Rudolph TK
JACC Cardiovasc Interv; 2016 Nov; 9(21):2200-2209. PubMed ID: 27832845
[TBL] [Abstract][Full Text] [Related]
3. Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus™ transcatheter aortic valve.
Zaman S; McCormick L; Gooley R; Rashid H; Ramkumar S; Jackson D; Hui S; Meredith IT
Catheter Cardiovasc Interv; 2017 Jul; 90(1):147-154. PubMed ID: 27862860
[TBL] [Abstract][Full Text] [Related]
4. A Highly Predictive Risk Model for Pacemaker Implantation After TAVR.
Maeno Y; Abramowitz Y; Kawamori H; Kazuno Y; Kubo S; Takahashi N; Mangat G; Okuyama K; Kashif M; Chakravarty T; Nakamura M; Cheng W; Friedman J; Berman D; Makkar RR; Jilaihawi H
JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1139-1147. PubMed ID: 28412434
[TBL] [Abstract][Full Text] [Related]
5. 1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study.
Manoharan G; Van Mieghem NM; Windecker S; Bosmans J; Bleiziffer S; Modine T; Linke A; Scholtz W; Chevalier B; Gooley R; Zeng C; Oh JK; Grube E
JACC Cardiovasc Interv; 2018 Nov; 11(22):2326-2334. PubMed ID: 30466832
[TBL] [Abstract][Full Text] [Related]
6. Computed tomography (CT) assessment of the membranous septal anatomy prior to transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 valve.
Oestreich BA; Mbai M; Gurevich S; Nijjar PS; Adabag S; Bertog S; Kelly R; Garcia S
Cardiovasc Revasc Med; 2018; 19(5 Pt B):626-631. PubMed ID: 29352699
[TBL] [Abstract][Full Text] [Related]
7. Development of a Risk Score to Predict New Pacemaker Implantation After Transcatheter Aortic Valve Replacement.
Kiani S; Kamioka N; Black GB; Lu MLR; Lisko JC; Rao B; Mengistu A; Gleason PT; Stewart JP; Caughron H; Dong A; Patel H; Grubb KJ; Greenbaum AB; Devireddy CM; Guyton RA; Leshnower B; Merchant FM; El-Chami M; Westerman SB; Lloyd MS; Babaliaros VC; Hoskins MH
JACC Cardiovasc Interv; 2019 Nov; 12(21):2133-2142. PubMed ID: 31699374
[TBL] [Abstract][Full Text] [Related]
8. Impact of the repositionable Evolut R CoreValve system on the need for a permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis.
Ojeda S; Hidalgo F; Romero M; Mazuelos F; Suárez de Lezo J; Martín E; Lostalo A; Luque A; González R; Fernández A; López-Aguilera J; Segura J; Guerrero N; Pan M
Catheter Cardiovasc Interv; 2020 Mar; 95(4):783-790. PubMed ID: 31062927
[TBL] [Abstract][Full Text] [Related]
9. Membranous septum length predicts conduction disturbances following transcatheter aortic valve replacement.
Chen YH; Chang HH; Liao TW; Leu HB; Chen IM; Chen PL; Lin SM
J Thorac Cardiovasc Surg; 2022 Jul; 164(1):42-51.e2. PubMed ID: 32891451
[TBL] [Abstract][Full Text] [Related]
10. Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.
Rampat R; Khawaja MZ; Hilling-Smith R; Byrne J; MacCarthy P; Blackman DJ; Krishnamurthy A; Gunarathne A; Kovac J; Banning A; Kharbanda R; Firoozi S; Brecker S; Redwood S; Bapat V; Mullen M; Aggarwal S; Manoharan G; Spence MS; Khogali S; Dooley M; Cockburn J; de Belder A; Trivedi U; Hildick-Smith D
JACC Cardiovasc Interv; 2017 Jun; 10(12):1247-1253. PubMed ID: 28641846
[TBL] [Abstract][Full Text] [Related]
11. Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry.
Sorajja P; Kodali S; Reardon MJ; Szeto WY; Chetcuti SJ; Hermiller J; Chenoweth S; Adams DH; Popma JJ
JACC Cardiovasc Interv; 2017 Oct; 10(20):2090-2098. PubMed ID: 29050627
[TBL] [Abstract][Full Text] [Related]
12. The influence of native aortic valve calcium and transcatheter valve oversize on the need for pacemaker implantation after transcatheter aortic valve insertion.
Al-Azzam F; Greason KL; Krittanawong C; Williamson EE; McLeod CJ; King KS; Mathew V
J Thorac Cardiovasc Surg; 2017 May; 153(5):1056-1062.e1. PubMed ID: 28073567
[TBL] [Abstract][Full Text] [Related]
13. Short membranous septum length in bicuspid aortic valve stenosis increases the risk of conduction disturbances.
Hamdan A; Nassar M; Schwammenthal E; Perlman G; Arow Z; Lessick J; Kerner A; Barsheshet A; Assa HV; Assali A; Aviv Y; Goitein O; Brodov Y; Codner P; Orvin K; Biton D; Klein E; Danenberg H; Finkelstein A; Kornowski R
J Cardiovasc Comput Tomogr; 2021; 15(4):339-347. PubMed ID: 33153946
[TBL] [Abstract][Full Text] [Related]
14. Prosthesis depth and conduction disturbances after last generation balloon-expandable transcatheter aortic valve implantation.
Iacovelli F; Pignatelli A; Giugliano G; Stabile E; Cicala M; Salemme L; Cioppa A; Popusoi G; Pucciarelli A; Verdoliva S; Bortone AS; Losi MA; Coscioni E; Esposito G; Contegiacomo G; Tesorio T
Europace; 2018 Jan; 20(1):116-123. PubMed ID: 28339584
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.
Chamandi C; Barbanti M; Munoz-Garcia A; Latib A; Nombela-Franco L; Gutiérrez-Ibanez E; Veiga-Fernandez G; Cheema AN; Cruz-Gonzalez I; Serra V; Tamburino C; Mangieri A; Colombo A; Jiménez-Quevedo P; Elizaga J; Laughlin G; Lee DH; Garcia Del Blanco B; Rodriguez-Gabella T; Marsal JR; Côté M; Philippon F; Rodés-Cabau J
JACC Cardiovasc Interv; 2018 Feb; 11(3):301-310. PubMed ID: 29413244
[TBL] [Abstract][Full Text] [Related]
16. Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
Alasti M; Rashid H; Rangasamy K; Kotschet E; Adam D; Alison J; Gooley R; Zaman S
Catheter Cardiovasc Interv; 2018 Oct; 92(4):777-782. PubMed ID: 29314625
[TBL] [Abstract][Full Text] [Related]
17. Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation for aortic stenosis using Medtronic new generation self-expanding CoreValve Evolut R.
Kaneko H; Hoelschermann F; Seifert M; Tambor G; Okamoto M; Moeller V; Neuss M; Butter C
Heart Vessels; 2019 Feb; 34(2):360-367. PubMed ID: 30083944
[TBL] [Abstract][Full Text] [Related]
18. Predictors for new-onset conduction block in patients with pure native aortic regurgitation after transcatheter aortic valve replacement with a new-generation self-expanding valve (VitaFlow Liberty
Zhang X; Liang C; Zha L; Zuo Q; Hu G; Ding J; Tang S
BMC Cardiovasc Disord; 2024 Jan; 24(1):77. PubMed ID: 38281925
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesis.
Droppa M; Rudolph TK; Baan J; Nielsen NE; Baumgartner H; Vendrik J; Froehlich M; Borst O; Wöhrle J; Gawaz M; Potratz P; Hack LP; Mauri V; Baranowski J; Bramlage P; Kurucova J; Thoenes M; Rottbauer W; Geisler T
Heart Vessels; 2020 Dec; 35(12):1735-1745. PubMed ID: 32591894
[TBL] [Abstract][Full Text] [Related]
20. Association between implantation depth assessed by computed tomography and new-onset conduction disturbances after transcatheter aortic valve implantation.
Almeida JG; Ferreira SM; Fonseca P; Dias T; Guerreiro C; Barbosa AR; Teixeira P; Carvalho M; Ferreira W; Ferreira ND; Oliveira M; Gonçalves H; Braga P; Ribeiro J; Primo J; Ribeiro VG
J Cardiovasc Comput Tomogr; 2017; 11(5):332-337. PubMed ID: 28844528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
